Using established criteria for grading dry eye severity, model dogs displaying moderate to severe clinical symptoms were selected to evaluate the therapeutic potential of ADMSC overexpressing SPARC in treating dry eye. The gene discussed is SPARC; the disease is dry eye syndrome.